2018 American Transplant Congress
Risk Factors of De Novo Malignancies after Liver Transplantation
De novo malignancies after liver transplantation (LT) are one of the leading causes of late mortality, with a reported risk of malignancies twice as high…2018 American Transplant Congress
Transplant Trends in Young Adults: Silent Alcohol Epidemic
1Gastroenterology, USF, Tampa; 2Transplant Hepatology, Tampa General Medical Group, Tampa.
With the introduction of effective antiviral therapy for HCV, there is a paradigm shift in liver disease with a decline in HCV but a parallel…2018 American Transplant Congress
Sustained Improvement in Patient Reported Outcomes 10 Years after Liver Transplantation by Protocol Longitudinal Assessment of Health Related Quality of Life
Purpose: Data on patient (pt) reported outcomes, especially beyond the first year after liver transplantation (LT) are scarce. We examined changes in health related quality…2018 American Transplant Congress
Kidney Transplantation Alone in End-Stage Renal Disease Patients with Hepatitis B Liver Cirrhosis
BackgroundKidney transplantation (KT) alone in end-stage renal disease (ESRD) patients with hepatitis B virus-induced liver cirrhosis (LC) remains controversial. This study compared outcomes of KT…2018 American Transplant Congress
Protein S Deficiency as an Independent Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients Awaiting Liver Transplantation
Background: Portal vein thrombosis (PVT) in cirrhotic patients not only induces lethal complications on waiting, but also complicates surgical procedures and increases risk during transplantation.…2017 American Transplant Congress
Porta Systemic Shunts Helps Us to Delay or Avoid Liver Transplantation in Patients with Portal Hypertension Post Kasai Operation for Biliary Atresia.
Paediatric Surgery and Transplant Surgery, Children's Hospital at Westmead, Sydney, NSW, Australia
We present a series of 10 patients who had Kasai operation for biliary atresia in the neonatal period. These patients had optimally functioning liver in…2017 American Transplant Congress
Disparities in Access to the Liver Transplant Wait List: A Statewide Analysis.
Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA
Background:Racial disparities in access to the liver transplant wait list for patients with end-stage liver disease (ESLD) are thought to be attributable to differences in…2017 American Transplant Congress
Are ICD-9 V Codes Representative of the Liver Transplant Wait List?
Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA
Background: Disparities in liver transplantation once wait listed are well-described, but little is known about how and why only 20% of end-stage liver disease patients…2017 American Transplant Congress
The Objective Liver Frailty Index Significantly Improves the Clinician “Eyeball Test” to Predict Mortality in Liver Transplant Candidates.
Background: Frailty is a critical determinant of waitlist outcomes. The most commonly-used test to assess frailty in liver transplant (LT) candidates is the “eyeball test”,…2017 American Transplant Congress
A Novel Equation, GRAIL (GfR Assessment in Liver Disease) Correctly Classifies Patients with Reduced GFR and Predicts Development of ESRD.
1BUMC, Dallas, TX; 2USC, LA, CA; 3NW, Chicago, IL
Estimating glomerular filtration rate(CKD-EPI, MDRD-4, MDRD-6) is poor in liver patients with renal dysfunction(GFR<30ml/min). We developed a model for GFR Assessment In Liver disease(GRAIL) before…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- 14
- Next Page »